US3859299A - Dioxazolone isocyanates - Google Patents

Dioxazolone isocyanates Download PDF

Info

Publication number
US3859299A
US3859299A US306784A US30678472A US3859299A US 3859299 A US3859299 A US 3859299A US 306784 A US306784 A US 306784A US 30678472 A US30678472 A US 30678472A US 3859299 A US3859299 A US 3859299A
Authority
US
United States
Prior art keywords
phosgene
parts
acid
compounds
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US306784A
Other languages
English (en)
Inventor
Jurgen Hocker
Rudolf Merten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of US3859299A publication Critical patent/US3859299A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00

Definitions

  • This invention provides compounds of the general formula:
  • R is an aliphatic, cycloaliphatic, araliphatic, aromatic or heterocyclic radical having a valency of n m;
  • x is l or 2;
  • n is an integer of from 1 to 4.
  • n is an integer of from 1 to 4.
  • the isocyanates which are preferred according to the invention are those wherein R of the general formula above is a C to C alkyl, C to C cycloalkyl, C to C aralkyl or C to C aryl radical with a valency of m n and whereinx, m and n have the meanings given above.
  • lsocyanates which are more particularly preferred are those wherein m, n and x in the general formula are each equal to l, and R is a branched or unbranched C to C alkylene radical.
  • the radical, R, in the above formula may be substituted.
  • substituents are, for example, aryl radicals, preferably phenyl radicals; CN radicals; S- alkyl and alkoxy groups which preferably contain 1 to 4 carbon atoms; dialkyl substituted amino groups, preferably those which are substituted with lower aliphatic radicals, preferably containing 1 to 4 carbon atoms; halogen atoms, preferably fluorine, chlorine or bromine; lower halogenated alkyl radicals, preferably containing l to 4 carbon atoms and preferably substituted with fluorine and/or chlorine or nitro groups; and in the case of aromatic and heterocyclic radicals the substituents may also be lower alkyl groups, preferably those containing 1 to 4 carbon atoms.
  • Me is a p-valent metal, preferably Li, Na, K, Be, Mg, Ca, Sr, Ba, B, ALFe, Co, Ni, Hg, Cr, Zn, Pb, Mn or Sb; and
  • p represents an integer of from 1 to 4; with phosgene or oxalyl chloride at temperatures of between about -25C. and about 200C, if desired, in an inert solvent.
  • Me represents any metal having a valency of p, preferably metals of the First and Second Main Group of the Periodic System and in particular Li, Na, K, Be, Mg, Ca, Sr, Ba, B, A], Fe, Co, Ni, Hg, Cr, Zn, Pb, Mn
  • the preferred metal salts of amino hydroxamic acids are the sodium or potassium salts.
  • Preferred starting compounds for use in the process are the sodium or potassium salts of:
  • metal salt of an aminohydroxamic acid a metal salt of e-aminocapro hydroxamic acid, the sodium or potassium salt of e-aminocapro-hydroxamic acid being particularly preferred.
  • the metal salts of aliphatic m-amino-hydroxamic acids are easily obtained by the ring opening of cyclic lactams with one equivalent of hydroxylamine and one equivalent of Me(OH), in the presence or absence of a solvent.
  • a salt of hydroxylamine for example, hydroxyl ammonium chloride or hydroxyl ammonium sulphate, with twice the equivalent quantity of Me(OH),
  • the ring opening of the lactam is preferably carried out in a solvent in which the metal salt of the aminohydroxamic acid can subsequently be reacted directly with phosgene or oxalyl chloride without having first to be isolated. In some cases, however, it may be advantageous to isolate the metal salt of the amino hydroxamic acid.
  • the process of preparing the compounds according to the invention is preferably carried out by introducing the metal salt of the aminohydroxamic acid into a solution of phosgene or oxalyl chloride in a suitable solvent at temperatures of between about 20C. and about 200C., preferably between about and about 50C. If the process is carried out with phosgene, the temperature is raised to about 60150C. while more phosgene isintroduced. After removal of the excess phosgene, the compound of the invention is separated from the solvent by distillation or by extraction with some other suitable solvent. The process may also be carried out by introducing the metal salt of aminohydroxamic acid-(4');
  • the inert solvents customarily used for phosgenation are suitable, some of which are, for example, benzene, toluene, xylene, chlorobenzene, o-dichlorobenzene, and chloronaphthalenes.
  • Solvents which are particularly suitable for use in the process are tetramethylenesulphone, dioxane, tetrahydrofuran and tetramethylurea.
  • a variation of the process of reacting metal salts of aminohydroxamic acids with phosgene comprising a 2-phase phosgenation which is carried out as follows: A solution of the metal salt of aminohydroxamic acid and a base in water is mixed by suitable means with a solution of phosgene in a solvent which is immiscible with water in such a way that the temperature is maintained between about 25C. and about 30C. The two phases are then separated and the compounds according to the invention are obtained by recrystallization or low temperature recrystallization after removal of the solvent by distillation under reduced pressure.
  • Both inorganic and organic bases may be used in the I process, however, NaOH and KOH are especially suitable.
  • the solvents which are immiscible with water may be any solvents of the kind that are inert to phosgene and to the base employed. Methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, benzene, toluene, xylene, chlorobenzene and dichlorobenzene are especially suitable.
  • the quantity of phosgene used is about 2 mols per mol of metal salt of aminohydroxamic acid but may be less, however, the phosgene is preferably used in excess.
  • the quantity of base used is preferably so calculated that after completion of the reaction the aqueous phase has a pH of between 5 and 9.
  • the reaction temperature should be between about 25C. and about 30C. preferably between about 10C. and about 5C.
  • the metal salt of aminohydroxamic acid is preferably a metal salt of e-amino-capro-hydroxamic acid, preferably the sodium or potassium salt.
  • the compounds according to the invention have characteristic absorptions in the IR spectrum. In addition to the isocyanate absorption at 2240 to 2280 cm, characteristic double 'bands occur at 1820 to 1880 cm for the ring system I and at 1770 to 1830 cm for the ring system II:
  • the isocyanate compounds of the invention may be used in known applications in the areas of isocyanate and urethane chemistry, for example, they may be utilized as the isocyanate precursor in the manufacture of polyurethane plastics, by the well-known isocyanate polyaddition process.
  • the isocyanate compounds of the invention may easily be converted to polyisocyanates simply by heating to expel carbon dioxide, respectively a mixture of carbon dioxide and carbon monoxide.
  • the compounds of the invention are, however, also capable to undergo an addition reaction e.g. with alcoholic hydroxyl compounds at their ring moiety without expelling carbon dioxide if they are reacted with hydroxyl compounds at moderate temperatures.
  • an addition reaction e.g. with alcoholic hydroxyl compounds at their ring moiety without expelling carbon dioxide if they are reacted with hydroxyl compounds at moderate temperatures.
  • polymers having interesting mechanical properties e.g. by reacting the compound which is hereinafter described in example 1 with hydroxy polyesters whereby the ring moiety forms an alkoxy carbonyl hydroxamate group according to following reaction scheme (R stands for the radical obtained by removing 1 hydroxy group from an hydroxy polyester):
  • EXAMPLES EXAMPLE 1 About 200 parts of phosgene are condensed in about 910 parts of anhydrous toluene at about-C., and about 96 parts of the sodium salt of e-amino-caprohydroxamic acid are introduced incrementally. The reaction mixture is slowly heated to about 90-95C. while phosgene is introduced. Phosgenation is then continued for about 5 hours at about 95C. and excess phosgene is then blown out with nitrogen.
  • reaction mixture is filtered, the solvent is removed by evaporation under vacuum and about 32 parts of a compound having characteristic absorption in the IR spectrum at 2260 cm (NCO group) and at 1820 and 1860 cm (dioxazolinone ring) are obtained, said compound having the following formula:
  • 1 mol of this compound is reacted with a polyester having an OH-number of 225 and which has been prepared by reacting 3 molar portions of butylene glycol, 3 molar portions of trimethylol propane, 4 molar portions of adipic acid and 1 molar portion of phthalic acid.
  • the amount of polyester has been such to provide one OH-group for each NCO group and one further OH group for each dioxazolidone group.
  • the reactants are mixed at approximately 50C and are subsequently heated for minutes to 80C.
  • a polymer containing urethane and alcoxycarbonylhydroxamate groups is obtained which can be used as binder for lacquers having good mechanical properties.
  • EXAMPLE 2 About 40 parts of phosgene are condensed in about 200 parts of anhydrous tetramethylene sulphone, and about 16.8 parts of the sodium salt of e-aminocaprohydroxamic acid are introduced incrementally at about 10C. The reaction mixture is slowly heated to about 120C. and phosgene is introduced for about 30 minutes and phosgenation is continued for a further 30 minutes at about 135C. The nitrogen is blown out and precipitated sodium chloride is removed by filtration and traces of phosgene and hydrochloric acid are removed under vacuum at about 100C. The resulting solution contains about 13.8 parts by weight of the compound prepared in Example 1 as indicated by titration with n-dibutylamine and gas chromatography.
  • EXAMPLE 3 A solution of about 16.8 parts of the sodium salt of e-aminocaprohydroxamic acid and about 16.8 parts of NaOH in about parts of water and a solution of about 20 parts of phosgene in about 80 parts of methylene chloride are introduced at equal rates into a solution of about 4 parts of phosgene in about 50 parts of methylene chloride at about 10C. with vigorous stirring. The phases are separated, the aqueous phase is extracted with methylene chloride. the methylene chloride phases are dried over sodium sulphate and the solvent is removed under vacuum.
  • EXAMPLE 4 A solution of about 16.8 parts of the sodium salt of e-aminocaprohydroxamic acid and about 28 parts of NaOH in about 200 parts of water and a solution of about 26 parts of phosgene in about parts of methylene chloride are introduced at equal rates into a solution of about 4 parts of phosgene in about 25 parts of methylene chloride at 0 to 10C. with vigorous stirring.
  • the reaction mixture is further processed as described in Example 3 and about 6.0 parts of the compound of Example 1 which has the characteristic 1R absorptions are obtained.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
US306784A 1971-11-26 1972-11-15 Dioxazolone isocyanates Expired - Lifetime US3859299A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2158740A DE2158740C2 (de) 1971-11-26 1971-11-26 5-(5-Isocyanatopentyl)-1,3,4-dioxazolinon-(2)

Publications (1)

Publication Number Publication Date
US3859299A true US3859299A (en) 1975-01-07

Family

ID=5826269

Family Applications (1)

Application Number Title Priority Date Filing Date
US306784A Expired - Lifetime US3859299A (en) 1971-11-26 1972-11-15 Dioxazolone isocyanates

Country Status (8)

Country Link
US (1) US3859299A (enrdf_load_stackoverflow)
JP (1) JPS563869B2 (enrdf_load_stackoverflow)
BE (1) BE791826A (enrdf_load_stackoverflow)
DE (1) DE2158740C2 (enrdf_load_stackoverflow)
FR (1) FR2163083A5 (enrdf_load_stackoverflow)
GB (1) GB1371679A (enrdf_load_stackoverflow)
IT (1) IT973648B (enrdf_load_stackoverflow)
NL (1) NL7215892A (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966721A (en) * 1973-12-19 1976-06-29 Ciba-Geigy Corporation Oxa- and thia-diazin-2-ones
US4002601A (en) * 1974-09-28 1977-01-11 Bayer Aktiengesellschaft Urethane oxazolidines
US4623661A (en) 1985-04-26 1986-11-18 Abbott Laboratories Lipoxygenase inhibiting compounds

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57194964A (en) * 1981-05-19 1982-11-30 Toppan Printing Co Ltd Cover with faucet and its manufacture
JPS57202959U (enrdf_load_stackoverflow) * 1981-06-19 1982-12-24
JPS60110270U (ja) * 1983-12-28 1985-07-26 東洋製罐株式会社 容器の切裂き部構造

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182068A (en) * 1962-05-09 1965-05-04 Bayer Ag Certain 3-aryl-1, 4, 2-oxathiazol-one-5-compounds
US3335131A (en) * 1962-04-02 1967-08-08 Interchem Corp Preparation of certain tris-aziridinylphosphine oxides or sulfides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620415A1 (de) * 1965-10-22 1970-03-12 Sinclair Research Inc Verfahren zur Herstellung einer neuen Klasse von organischen Verbindungen
US3658805A (en) * 1966-11-07 1972-04-25 Atlantic Richfield Co Cyclic nitrile oxalate compounds
BE755460A (fr) * 1969-08-28 1971-02-01 Bayer Ag Isocyanates de s-triazinyle, leur preparation et leur utilisation dans la fabrication de resines de polyurethanes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3335131A (en) * 1962-04-02 1967-08-08 Interchem Corp Preparation of certain tris-aziridinylphosphine oxides or sulfides
US3182068A (en) * 1962-05-09 1965-05-04 Bayer Ag Certain 3-aryl-1, 4, 2-oxathiazol-one-5-compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966721A (en) * 1973-12-19 1976-06-29 Ciba-Geigy Corporation Oxa- and thia-diazin-2-ones
US4002601A (en) * 1974-09-28 1977-01-11 Bayer Aktiengesellschaft Urethane oxazolidines
US4623661A (en) 1985-04-26 1986-11-18 Abbott Laboratories Lipoxygenase inhibiting compounds

Also Published As

Publication number Publication date
JPS4857976A (enrdf_load_stackoverflow) 1973-08-14
DE2158740A1 (de) 1973-05-30
JPS563869B2 (enrdf_load_stackoverflow) 1981-01-27
DE2158740C2 (de) 1982-07-01
NL7215892A (enrdf_load_stackoverflow) 1973-05-29
IT973648B (it) 1974-06-10
FR2163083A5 (enrdf_load_stackoverflow) 1973-07-20
GB1371679A (en) 1974-10-23
BE791826A (fr) 1973-05-23

Similar Documents

Publication Publication Date Title
US3454606A (en) Isocyanatophenylsulfonyl isocyanates
US3567763A (en) Ester polyisocyanates
US2866801A (en) Process for the production of organic isocyanates
US4129741A (en) Novel polyethers having terminal amino groups, a process for their production and their application
JP2018507932A (ja) 高い安定性を有するポリオキサゾリジノン化合物の合成方法
KR100296482B1 (ko) 4-치환된비스(2,6-디이소프로필페닐)카르보디이미드,이들의제조방법,이들의사용방법,및이들의제조에사용되는4-치환된2,6-디이소프로필페닐이소시아네이트
US4247677A (en) Novel polyethers having terminal amino groups and plastic materials made therefrom
US3859299A (en) Dioxazolone isocyanates
US4146723A (en) Heterocyclic diisocyanates and a process for making polyurethanes and polyurethane-ureas
GB2029413A (en) Preparation of organic mono- and polyisocyanates
US4255570A (en) Polyisocyanate reaction products of diisocyanates and s-triazine derivatives containing amino groups
US3322812A (en) Alkyl isocyanatoalkyl carbonates
JPS5918722A (ja) ポリイソシアヌレ−ト塩類とその製法
US3939200A (en) Aliphatic acyl-containing amine hydrochlorides
JPS6131101B2 (enrdf_load_stackoverflow)
US3100790A (en) Isocyanoaryl esters of phosphonic, phosphinic, thiophosphonic, and thiophosphinic acids
US3509198A (en) Preparation of 2-chlorocarbonyl-phenylisocyanates
JPS5826853A (ja) Ｎ，ｎ−ジ置換スルホンアミド基を含んでいる芳香族ジイソシアネ−トおよびその製造方法
US3267122A (en) Bis-(gamma-isocyanato)-alkoxy alkanes and preparation thereof
JPS6315264B2 (enrdf_load_stackoverflow)
US4567287A (en) Preparation of carbamates from organic carbonates and aromatic ureas
US4263221A (en) Process for the preparation of aromatic carbodiimides
US3794667A (en) Isocyanato-p-quinones
US4009152A (en) Diisocyanato-diketenes
US4454071A (en) Isocyanatoaryl sulphochlorides